Figure 2

Correlations between the percentage of LINE-1 methylation and IFNβ treatment duration. (A) In IFNβ-treated MS patients. (B) In treated patients without clinical activity: there was a significant negative correlation between LINE-1 methylation and treatment duration. (C) In treated patients with clinical activity there was not a significant correlation.